1. Home
  2. LCUT vs ARMP Comparison

LCUT vs ARMP Comparison

Compare LCUT & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$8.76

Market Cap

191.1M

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$3.87

Market Cap

156.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
ARMP
Founded
1945
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.1M
156.4M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
LCUT
ARMP
Price
$8.76
$3.87
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$15.00
AVG Volume (30 Days)
241.6K
223.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$2.32
52 Week High
$9.80
$14.98

Technical Indicators

Market Signals
Indicator
LCUT
ARMP
Relative Strength Index (RSI) 54.62 23.81
Support Level $7.57 N/A
Resistance Level $9.61 $7.67
Average True Range (ATR) 0.67 0.59
MACD 0.01 -0.15
Stochastic Oscillator 66.32 9.40

Price Performance

Historical Comparison
LCUT
ARMP

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: